Equity
Treasury Stock
ResMed Treasury Stock increased by 7.4% to $2.58B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 30.6%, from $1.97B to $2.58B. Over 4 years (FY 2021 to FY 2025), Treasury Stock shows an upward trend with a 6.3% CAGR.
Analysis
StatementBalance Sheet Statement
SectionEquity
CategoryCapital Allocation
SignalContext dependent
VolatilityModerate
First reportedQ3 2021
Last reportedQ4 2025
How to read this metric
An increase indicates active share buybacks, which can signal management's confidence in the stock or an effort to return capital to shareholders.
Detailed definition
Treasury stock represents the cost of shares that a company has repurchased from the open market and holds in its own tr...
Peer comparison
Standard across all public companies; peers in the pharmaceutical sector often use buybacks to manage earnings per share.
Metric ID:
treasury_stockHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.62B | $1.62B | $1.62B | $1.62B | $1.62B | $1.62B | $1.62B | $1.62B | $1.62B | $1.62B | $1.67B | $1.72B | $1.77B | $1.82B | $1.90B | $1.97B | $2.07B | $2.22B | $2.40B | $2.58B |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +3.1% | +3.0% | +2.9% | +2.8% | +4.1% | +4.0% | +5.1% | +7.2% | +8.0% | +7.4% |
| YoY Change | — | — | — | — | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +3.1% | +6.2% | +9.2% | +12.3% | +13.4% | +14.5% | +16.9% | +21.9% | +26.4% | +30.6% |
Range$1.62B – $2.58B
CAGR+10.2%
Avg YoY Growth+9.7%
Median YoY Growth+7.7%
Current Streak19+ quarters growth
Treasury Stock at Other Companies
Frequently Asked Questions
- What is ResMed's treasury stock?
- ResMed (RMD) reported treasury stock of $2.58B in Q1 2026.
- How has ResMed's treasury stock changed year-over-year?
- ResMed's treasury stock increased by 30.6% year-over-year, from $1.97B to $2.58B.
- What is the long-term trend for ResMed's treasury stock?
- Over 4 years (2021 to 2025), ResMed's treasury stock has grown at a 6.3% compound annual growth rate (CAGR), from $1.62B to $2.07B.
- What does treasury stock mean?
- The value of shares a company has bought back from the market.